Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

Search

Top

GENENTECH USA, INC

Subsidiary ofROCHE HOLDING AGUEI: SA85BMHCTXK5CAGE: 53VP4

GENENTECH USA, INC is a federal contractor, registered under UEI SA85BMHCTXK5 and CAGE code 53VP4. It has been awarded $226,147,280 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Medicinal and Botanical Manufacturing, and Other NAICS codes (1 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Other agencies (4 agencies, <0.5% each).

Contact Information

Registration and classification details

Phone+1 (555) 000-0000

Websitewww.gene.com

Address123 Main St, City, ST 12345

Registration

UEI Code

SA85BMHCTXK5

CAGE Code

53VP4

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationForeign OwnedManufacturer of Goods

NAICS Codes

325411Medicinal and Botanical Manufacturing

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Genentech USA, Inc. specializes in the manufacturing of sterile pharmaceutical preparations, with deep expertise in aseptic processing, lyophilization, and finished dosage form production for critical-care and specialty therapeutics. The company delivers complex biologic and small-molecule products ...

Key Performance Metrics

Awards Count

510

All time

Active

3

Currently performing

Completed

507

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$166.6M73.7%Department Of Defense$58.0M25.7%

Other agencies (4 agencies, <0.5% each)$1.5M0.7%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$222.7M98.5%325411 - Medicinal and Botanical Manufacturing$3.4M1.5%

Others - Other NAICS codes (1 codes, <0.5% each)$63.5K0%

Awards by Agency Over Time

Awards by Place of Performance

Compete with GENENTECH USA, INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for GENENTECH USA, INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in GENENTECH USA, INC's top NAICS codes and agencies

Therapeutic Development for Drug-Resistant Infectious DiseasesThis subcontract focuses on the development of therapeutic candidates designed to treat drug-resistant infectious diseases in support of prime contractors for the National Institutes of Health and the National Institute of Allergy and Infectious Diseases. The scope of work encompasses the identification and synthesis of candidates, efficacy testing against resistant strains, and comprehensive safety profiling and toxicity testing. To successfully execute these tasks, the provider must possess specialized chemical synthesis equipment, antimicrobial susceptibility testing capabilities, and the necessary biosafety certifications. The primary deliverables for this engagement include validated therapeutic candidates, detailed safety and efficacy data, and strategic maturation plans. This opportunity is categorized under NAICS code 325412 and is associated with the Department of Health and Human Services. Interested parties should note the response deadline of December 8, 2026.

National Institutes Of Health Niaid

POSTED

DEADLINE

in about 2 months

SPF 50 Topical Sunscreen Preparation (NSN 6505-01-657-9247)This subcontract involves the supply of finished over-the-counter SPF 50 topical sunscreen for prime contractors supporting Department of Defense Medical Supply Chain projects. The required formula must be hypoallergenic, oil-free, PABA-free, and biodegradable, specifically containing 4.5 percent titanium dioxide and 4 percent zinc oxide. All products must be packaged in 3-ounce tubes in accordance with Medical Marking Standard No. 1 and ASTM D3951, with final delivery consisting of 24-tube packages shipped FOB Destination. The contract mandates strict compliance with the Buy American Act and the Berry Amendment. Identified by NSN 6505-01-657-9247 and NAICS code 325412, the project is managed under the Medical Supply Chain Pharm FSA. The place of performance is designated as FPO 96671-4077, with a response deadline set for October 14, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturer of Sterile Elastic Knuckle Fabric BandagesThis subcontract involves the manufacture of sterile, elastic knuckle fabric adhesive bandages for prime contractors supporting the Department of Defense Medical Supply Chain. The required bandages must measure 1.5 by 3 inches, utilizing rayon woven web material and latex-free adhesives. All products must undergo sterilization and labeling in accordance with Medical Marking Standard No. 1 and be delivered in cases of 1,200 units with a guaranteed shelf life of 60 months. Compliance with the Berry Amendment and the Buy American Act is mandatory for this contract. The project falls under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Interested parties should note the performance location is listed as FPO 96671-4077.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Dibucaine Ointment USP ManufacturingThis subcontract involves the manufacture and supply of 2,000 units of 1 oz / 28g 1% Dibucaine Ointment for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The contractor is responsible for formulating and producing the ointment in accordance with USP standards, ensuring a non-extendable shelf life of 36 months and maintaining strict temperature-controlled storage between 15 and 30 degrees Celsius during the production process. Compliance with FDA regulations and the Buy American Act is mandatory for this project. The performance of the contract is tied to NAICS code 325412, with the place of performance located at FPO 96661.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Antichap Lipstick Supply (NSN 6508-01-668-1197)This subcontract involves the supply of 400 units of hydrating antichap lipstick for prime contractors supporting the Department of Defense Medical Supply Chain Pharma FSA. The required product is a 0.15 ounce hydrating formula featuring UVA/UVB SPF 15 protection, provided in carry-on containers with hangers. All deliverables must maintain a minimum remaining shelf-life of 21 months and be stored at a controlled room temperature. Compliance with strict military and industry standards is mandatory, including ASTM D3951 for packaging, RP001 for palletization, and MIL-STD-129 for labeling. The project falls under NAICS code 325412 and is associated with NSN 6508-01-668-1197, with the place of performance located in Draper, Utah.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Acyclovir Tablets SupplierThis subcontract opportunity is for the supply of finished Acyclovir Tablets, specifically 800 mg tablets in bottles of 100, to support prime contractors on Department of Defense DLA Troop Support Medical Supply Chain projects. The required delivery consists of 4 bottles of the medication, which must adhere to a Type I Code M classification with a non-extendable shelf life of 24 months. Eligible suppliers must maintain FDA registration and ensure full compliance with the Buy American Act. The performance of this contract is centered in Fort Bragg, and interested parties must submit their responses by October 14, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Permethrin Cream Rinse ManufacturerThis subcontract involves the formulation and manufacture of Permethrin Cream Rinse for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The manufacturer is responsible for producing a cream rinse with a 1% w/v Permethrin active ingredient using pharmaceutical-grade equipment, ensuring a 24-month shelf life. The final delivery consists of 11 units of 2 fl oz plastic squeeze bottles equipped with combs. Strict adherence to FDA drug manufacturing regulations and registration is required, along with compliance with Medical Marking Standard No. 1 and MIL-STD-129. The project falls under NAICS code 325412 and is designated for performance at FPO 96671-4077.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE ORAL TOPICA

Solicitation # SPE2DP-27-T-0076

Solicitation SPE2DP-27-T-0076 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Benzocaine Oral Topical Gel, 20%. The requirement consists of two bottles, each containing 1 oz (28g), identified by NSN 6505-01-064-5769. The product is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after order to HHC Headquarters in Oklahoma City, with shipping terms set as FOB Destination. The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129, and MIL-STD-2073-1E for preservation and packing. All items must be in suitable sealed unit containers and commercial exterior shipping containers. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system. Compliance with various federal regulations is required, including the Hazard Communication Standard for hazardous materials, DFARS 252.204-7012 for safeguarding covered defense information, and prohibitions on acquiring items from Communist Chinese military companies.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MOXIFLOXACIN HYDROC

Solicitation # SPE2DP-27-T-0079

Solicitation SPE2DP-27-T-0079, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of Moxifloxacin Hydrochloride tablets, 400 mg. The medication is required in bottles containing 30 tablets each, with a non-extendable shelf life of 36 months. The items must be stored at controlled room temperature and protected from high humidity. This is an FDA-regulated drug procurement involving multiple delivery lines to various vessel destinations, including the USS Ralph Johnson, USS Roosevelt, USS Gridley, and USS Lewis B Puller, with required delivery dates spanning from May to July 2026. The contract mandates strict adherence to DLA packaging and marking standards, specifically Medical Marking Standard No. 1, which takes precedence over MIL-STD-129. Packaging must comply with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, with palletization following RP001. Delivery is set as FOB Destination, with inspection and acceptance also occurring at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various DFARS and FAR clauses regarding cybersecurity, the Buy American Act, and the safeguarding of covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0080

Solicitation SPE2DP-27-T-0080, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product must contain a 1% w/v Permethrin active ingredient and be supplied in 2 fl oz plastic squeeze bottles that include a comb. The total quantity requested across four line items is 11 units. The product has a total shelf life of 24 months, with a strict requirement that at least 21 months of shelf life remain upon receipt by the first government activity. Delivery is required within 20 days after order to various destination points, including USNS Loyal, USNS Lewis and Clark, and USNS Leroy Grumman. As an FDA-regulated drug or device, the product must adhere to Medical Marking Standard No. 1 and MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers, with hazardous materials specifically complying with Federal Standard No. 313-E and TQ requirement IP025. Suppliers are required to submit Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award. Contract administration requires the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and prohibitions on covered defense telecommunications equipment. Quotations are due by October 14, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DIBUCAINE OINTMENT

Solicitation # SPE2DP-27-T-0077

Solicitation SPE2DP-27-T-0077, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of 2,000 packages of Dibucaine Ointment USP. This FDA-regulated drug contains 1 percent dibucaine ointment as the active ingredient and must be supplied in a collapsible tube with a rectal applicator. Each unit of issue consists of a one-ounce or 28-gram package. The product requires a non-extendable shelf life of 36 months and must be stored at temperatures between 15-30 degrees Celsius (59 to 86 degrees Fahrenheit). Delivery is required within 20 days after order, with a required delivery date of October 13, 2026, shipped FOB Destination to the USNS Richard E Byrd. Inspection and acceptance will occur at the destination per FAR 52.246-2. Packaging must comply with MIL-STD-129 and Medical Marking Standard No. 1, with non-hazardous materials following ASTM D3951 and hazardous materials following TQ requirement IP025. All payment requests and receiving reports must be processed electronically through the Wide Area Workflow system. The contract incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information and compliance with the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ACYCLOVIR TABLETS

Solicitation # SPE2DP-27-T-0081

Solicitation SPE2DP-27-T-0081 is a fixed-price procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for Acyclovir Tablets, NSN 6505-01-341-9964. The requirement is for 4 bottles of 800 mg tablets, with each bottle containing 100 tablets. Delivery is required within 5 days after receipt of order to a destination in Fort Bragg, NC, with a required delivery date of July 14, 2026. The items are classified as Type I Code M with a non-extendable shelf life of 24 months. The contractor must adhere to strict commercial packaging and packing requirements to prevent damage, with all materials marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Invoicing and receiving reports must be processed electronically through the Wide Area Workflow system. This procurement is subject to various federal and defense regulations, including the Buy American Act, DFARS safeguarding of covered defense information, and prohibitions on the intentional addition of mercury to supplies. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Radiopharmaceutical Cold Kit and Unit Dose SupplierThis subcontract involves the manufacture and supply of radiopharmaceutical kits and unit doses to support prime contractors on Department of Veterans Affairs nuclear medicine projects. The scope of work includes providing Cold Kits such as MAA, MDP, Mebrofenin, and PYP, as well as Tc99m, I-123, and In-111 variants. Additionally, the supplier must provide bar-labeled inserts that are compatible with the PineStar Nuclear Medicine Information Management System, with all deliveries directed to secure location room 3A101B. To qualify for this contract, the provider must maintain a valid NRC license and accreditation while ensuring full compliance with DOT, NHPP, FDA, and OSHA regulations. Managed by the Department of Veterans Affairs Network Contract Office 4, the project falls under NAICS code 325412 and is centered in the 19104 zip code area.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center

Solicitation # 36C24427Q0018

The Department of Veterans Affairs, Network Contracting Office 4, is soliciting quotations for an indefinite-quantity contract to provide essential radiopharmaceuticals and calibration sources for the Corporal Michael J. Crescenz VA Medical Center Nuclear Medicine Department. The contract covers a five-year period of performance from November 1, 2026, to October 31, 2031, consisting of a base year and four option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, NHPP, FDA, and OSHA. Deliveries are to be made to a secure location at the medical center, with routine orders due by 8:00 AM the following workday and same-day deliveries required within two hours of order placement during normal business hours. The scope of work includes the supply of various radiopharmaceutical kits and calibration sources, such as Co57 and Tc99m variants. Contractors must ensure all radioactive materials are clearly labeled with proper class and exposure levels, and unit doses must include preparation and expiration details. Additionally, the vendor must provide bar-labeled inserts compatible with the PineStar Nuclear Medicine Information Management System or provide a compatible system, including data migration and training, at no additional cost. Award will be based on a comparative evaluation of price and past performance, with a preference for HUBZone Small Business Concerns. Quotations must be submitted electronically to the Contracting Officer in two parts: a price quotation and past performance information from the last three years. Invoicing is to be handled monthly and submitted electronically via the Austin Payment Center.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9404

Defense Health Agency (dha)

POSTED

DEADLINE

Inhaled Nitric Oxide

Solicitation # HT940827Q0002

The Defense Health Agency intends to award a sole source contract to INO Therapeutics LLC for the procurement and delivery of Inhaled Nitric Oxide for the Department of Medicine at Brooke Army Medical Center in Fort Sam Houston, Texas. The contract covers a base period from January 1, 2027, to December 31, 2027, with four additional option years. The scope of work includes the supply of 800 PPM nitric oxide for inhalation, a specialized delivery device, all necessary maintenance and calibration accessories, and comprehensive support services such as training and logistics. This notice serves as a sources-sought inquiry to determine if other capable vendors exist before finalizing the sole source award. Interested parties must submit written evidence of their capability to meet all technical requirements to Contracting Officer Joe D. Wells by October 22, 2026, at 12:00 PM CST. Submissions must demonstrate that competition would be beneficial to the government without being cost or schedule prohibitive.

Defense Health Agency

POSTED

DEADLINE

Blood Cell Staining Kit SupplierThis subcontract involves the supply of specialized Blood Cell Staining Kits for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required kits must feature Wright's stain compatible with Ames Hematek slide stainers, utilizing Romanowski type modified polychrome methylene blue or thiazine and xanthine dyes. All products must adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1. Key operational requirements include a strict manufacture-to-delivery timeline of one month and a minimum shelf life of 12 months. The contract specifies the delivery of one kit on a FOB Destination basis to a performance location in FPO 09566-4008. The opportunity is categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

in about 9 hours

Manufacturing of Witch Hazel Impregnated Pads (NSN 6510-01-047-5619)This subcontract involves the manufacturing and packaging of Witch Hazel Impregnated Pads under NSN 6510-01-047-5619 for the Department of Defense Medical Supply Chain. The contractor is responsible for fabricating 3-inch pads composed of 70 percent material and 30 percent synthetic non-toxic fiber, which are then impregnated with a specific solution of Witch Hazel Glycerin, Methylparaben, Benzalkonium Chloride, and purified water. Quality control requirements include performing pH testing to ensure a range between 4.2 and 4.8, with labeling that adheres to Medical Marking Standard No. 1 and MIL-STD-129. The finished product must be delivered in jars containing 40 pads each. This project falls under NAICS code 325412 and is performed for prime contractors supporting DLA Troop Support Medical Supply Chain projects.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

in about 9 hours